FDA Clearance Tracker · K201618
Nalu Neurostimulation SCS system
Last checked: Nov 19, 2026Latest source record: Jul 15, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Jul 15, 2020
Substantially Equivalent
Time to decision
30 days
Received Jun 15, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K201618
- Device name
- Nalu Neurostimulation SCS system
- Applicant
- Boston Scientific Neuromodulation
- Applicant location
- Valencia, CA
- Received
- Jun 15, 2020
- Decided
- Jul 15, 2020
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5880
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GZB. The earliest in FDA's data is K780001, decided Jan 17, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K201618
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Boston Scientific Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251247 · Decided Aug 7, 2025 · 106 days after receipt
Device type: Generator, Lesion, Radiofrequency (GXD) · Neurology & Neurosurgery
K233801 · Decided Aug 23, 2024 · 268 days after receipt
Device type: Stimulator, Spinal-Cord, Implanted (Pain Relief) (GZB) · Neurology & Neurosurgery
K232415 · Decided Aug 21, 2024 · 376 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.